X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-04-21 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $149.20 | -5,000 | 45,788 | -10% | -$746,000 | |||||
2021-04-21 | SWAV | Shockwave Medical, Inc. | Watkins Frank T | Dir | S - Sale | $149.08 | -2,000 | 82,952 | -2% | -$298,157 | ||||||
2021-04-21 | MMM | 3M Co | Ludgate Kristen M | EVP | S - Sale | $200.00 | -933 | 1,836 | -34% | -$186,600 | ||||||
| D | 2021-04-19 | AXNX | Axonics, Inc. | Ford Alfred J Jr | Chief Commercial Officer | S - Sale+OE | $58.56 | -54,296 | 5,625 | -91% | -$3,179,406 | |||||
2021-04-20 | SWAV | Shockwave Medical, Inc. | Watkins Frank T | Dir | S - Sale | $138.35 | -2,000 | 84,952 | -2% | -$276,697 | ||||||
2021-04-21 | INO | Inovio Pharmaceuticals, Inc. | Kies Peter | CFO | S - Sale | $8.52 | -10,000 | 165,288 | -6% | -$85,200 | ||||||
2021-04-19 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $43.24 | -4,797 | 121,470 | -4% | -$207,422 | ||||||
| D | 2021-04-21 | INO | Inovio Pharmaceuticals, Inc. | Weiner David B. | Dir | S - Sale+OE | $8.57 | -26,583 | 851,136 | -3% | -$227,694 | |||||
2021-04-19 | NARI | Inari Medical, Inc. | Hykes Andrew | COO | S - Sale | $103.18 | -9,000 | 210,261 | -4% | -$928,599 | ||||||
2021-04-16 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Chief Commercial Officer | S - Sale | $33.65 | -587 | 123,601 | 0% | -$19,752 | ||||||
2021-04-16 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | COB, Pres, CEO | S - Sale | $33.65 | -2,112 | 272,743 | -1% | -$71,068 | ||||||
2021-04-16 | SIBN | Si-Bone, Inc. | Pisetsky Michael A | GC, Chief Compliance Officer | S - Sale | $33.65 | -243 | 79,428 | 0% | -$8,177 | ||||||
2021-04-16 | HAE | Haemonetics Corp | Lingamneni Anila | EVP, CTO | S - Sale | $119.44 | -170 | 3,444 | -5% | -$20,305 | ||||||
2021-04-16 | SRDX | Surmodics Inc | Olson Charles W | SVP of Bus Dev, Med Dev | S - Sale | $59.75 | -648 | 42,892 | -1% | -$38,718 | ||||||
| DM | 2021-04-16 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $137.92 | -2,500 | 45,788 | -5% | -$344,788 | |||||
| M | 2021-04-15 | AXNX | Axonics, Inc. | Sama Rinda | COO | S - Sale | $59.08 | -75,000 | 43,295 | -63% | -$4,430,689 | |||||
| D | 2021-04-16 | IART | Integra Lifesciences Holdings Corp | Coleman Glenn | EVP, COO | S - Sale+OE | $71.50 | -25,658 | 32,056 | -44% | -$1,834,547 | |||||
| M | 2021-04-15 | ICUI | Icu Medical Inc/de | Lopez George A | Dir, 10% | S - Sale | $209.01 | -25,000 | 1,152,157 | -2% | -$5,225,298 | |||||
| D | 2021-04-15 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Chief Commercial Officer | S - Sale+OE | $138.57 | -4,000 | 51,050 | -7% | -$554,292 | |||||
| D | 2021-04-16 | INO | Inovio Pharmaceuticals, Inc. | Benito Simon X | Dir | S - Sale+OE | $8.75 | -2,000 | 51,650 | -4% | -$17,500 | |||||
2021-04-15 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $43.75 | -26,000 | 1,252,455 | -2% | -$1,137,556 | ||||||
2021-04-15 | DXCM | Dexcom Inc | Flynn Paul R | EVP, Global Revenue | S - Sale | $400.00 | -758 | 12,306 | -6% | -$303,200 | ||||||
| D | 2021-04-15 | BSX | Boston Scientific Corp | Butcher Arthur C | EVP, Pres, Asia Pacific | S - Sale+OE | $40.00 | -9,676 | 31,952 | -23% | -$387,040 | |||||
| D | 2021-04-15 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $40.95 | -28,123 | 139,158 | -17% | -$1,151,640 | |||||
2021-04-15 | RMD | Resmed Inc | Douglas Robert Andrew | Pres, COO ResMed Inc. | S - Sale | $207.45 | -964 | 227,108 | 0% | -$199,982 | ||||||
2021-04-13 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale | $199.55 | -95,000 | 555,393 | -15% | -$18,957,452 | ||||||
2021-04-13 | NVCR | Novocure Ltd | Danziger Asaf | CEO | S - Sale | $196.34 | -97,973 | 8,184 | -92% | -$19,236,323 | ||||||
| D | 2021-04-13 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $198.84 | -6,000 | 72,045 | -8% | -$1,193,035 | |||||
| D | 2021-04-13 | NVCR | Novocure Ltd | Benaim Ely | Chief Medical Officer | S - Sale+OE | $200.00 | -5,958 | 33,259 | -15% | -$1,191,600 | |||||
2021-04-14 | ANGO | Angiodynamics Inc | Helsel Dave | SVP Global Operations, R, D | S - Sale | $23.93 | -3,500 | 19,115 | -15% | -$83,755 | ||||||
2021-04-14 | IART | Integra Lifesciences Holdings Corp | Coleman Glenn | EVP, COO | S - Sale | $70.50 | -4,002 | 32,056 | -11% | -$282,141 | ||||||
| D | 2021-04-14 | IART | Integra Lifesciences Holdings Corp | Evoli Lisa | EVP,CHRO | S - Sale+OE | $70.00 | -6,306 | 7,825 | -45% | -$441,420 | |||||
| M | 2021-04-01 | TOMDF | Todos Medical Ltd. | Strategic Investment Holdings, LLC | 10% | S - Sale | $0.07 | -3,321,864 | 45,036,321 | -7% | -$246,049 | |||||
| M | 2020-01-21 | TOMDF | Todos Medical Ltd. | Strategic Investment Holdings, LLC | 10% | P - Purchase | $0.07 | +48,708,185 | 48,358,185 | -13917% | +$3,442,891 | |||||
2021-03-31 | TOMDF | Todos Medical Ltd. | Strategic Investment Holdings, LLC | 10% | S - Sale | $0.05 | -350,000 | 48,358,185 | -1% | -$18,400 | ||||||
| D | 2021-04-12 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale+OE | $49.73 | -11,000 | 215,459 | -5% | -$547,067 | |||||
2021-04-12 | NUVA | Nuvasive Inc | Vitale Lucas | CHRO | S - Sale | $68.19 | -4,306 | 3,151 | -58% | -$293,626 | ||||||
2021-04-12 | NUVA | Nuvasive Inc | Calafiore Massimo | EVP, Global Business Units | S - Sale | $68.19 | -3,498 | 112 | -97% | -$238,529 | ||||||
2021-04-12 | BAX | Baxter International Inc | Frye Andrew | SVP, Pres, APAC | S - Sale | $84.79 | -10,999 | 9,041 | -55% | -$932,605 | ||||||
2021-04-12 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale | $200.00 | -4,800 | 83,046 | -5% | -$960,000 | ||||||
2021-04-12 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $198.47 | -2,500 | 94,922 | -3% | -$496,175 | ||||||
2021-04-05 | APEN | Apollo Endosurgery, Inc. | Gagnon Neil | 10% | P - Purchase | $5.48 | +303 | 1,828,560 | 0% | +$1,661 | ||||||
| M | 2021-04-08 | ICUI | Icu Medical Inc/de | Lopez George A | Dir, 10% | S - Sale | $204.07 | -25,000 | 1,177,157 | -2% | -$5,101,759 | |||||
2021-04-09 | NARI | Inari Medical, Inc. | Milder Donald B | Dir, 10% | S - Sale | $112.19 | -7,000 | 4,818,455 | 0% | -$785,300 | ||||||
| D | 2021-04-09 | IART | Integra Lifesciences Holdings Corp | Coleman Glenn | EVP, COO | S - Sale+OE | $70.00 | -12,500 | 36,058 | -26% | -$875,000 | |||||
| D | 2021-04-09 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $112.21 | -5,000 | 69,537 | -7% | -$561,027 | |||||
| DM | 2021-04-08 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, People, Culture, GC | S - Sale+OE | $16.57 | -30,840 | 1,102,521 | -3% | -$510,870 | |||||
| D | 2021-04-08 | HRC | Hill-Rom Holdings, Inc. | Johnson Paul Sherwood | SVP, Pres - PSS Acute Care | S - Sale+OE | $111.04 | -11,575 | 6,221 | -65% | -$1,285,327 | |||||
2021-04-08 | SYK | Stryker Corp | Fink M Kathryn | VP, CHRO | S - Sale | $250.00 | -4,000 | 10,556 | -27% | -$1,000,000 | ||||||
| A | 2021-03-23 | NVCR | Novocure Ltd | Weinberg Uri | Chief Science Officer | S - Sale | $140.00 | -2,835 | 33,471 | -8% | -$396,900 | |||||
2021-04-06 | LUNG | Pulmonx Corp | Boston Scientific Corp | 10% | S - Sale | $43.60 | -650,000 | 3,988,106 | -14% | -$28,340,000 | ||||||
2020-02-28 | NVCR | Novocure Ltd | Groenhuysen Wilhelmus Cm | COO | S - Sale | $72.22 | -3,670 | 150,014 | -2% | -$265,029 | ||||||
| A | 2021-04-05 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $47.65 | -4,797 | 104,267 | -4% | -$228,557 | |||||
| D | 2021-04-05 | BAX | Baxter International Inc | Stroucken Albert P L | Dir | S - Sale+OE | $84.56 | -4,990 | 32,592 | -13% | -$421,954 | |||||
| D | 2021-04-05 | BAX | Baxter International Inc | Hellman Peter S | Dir | S - Sale+OE | $84.56 | -4,990 | 25,959 | -16% | -$421,954 | |||||
2021-04-05 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | COB, Pres, CEO | S - Sale | $30.56 | -40,000 | 333,043 | -11% | -$1,222,321 | ||||||
2021-04-05 | DXCM | Dexcom Inc | Sayer Kevin R | COB, CEO, Pres | S - Sale | $366.67 | -6,221 | 111,257 | -5% | -$2,281,082 | ||||||
2021-04-05 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale | $106.40 | -150,000 | 953,223 | -14% | -$15,960,258 | ||||||
2021-04-05 | SILK | Silk Road Medical Inc | Davis Andrew S. | Chief Commercial Officer | S - Sale | $51.16 | -660 | 31,240 | -2% | -$33,767 | ||||||
2021-04-05 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $47.64 | -4,797 | 109,064 | -4% | -$228,521 | ||||||
| M | 2021-04-05 | LUNG | Pulmonx Corp | Sung Derrick | CFO | S - Sale | $47.36 | -10,000 | 218,659 | -4% | -$473,622 | |||||
2021-04-05 | DYNT | Dynatronics Corp | Baker Brian D. | Dir | P - Purchase | $0.00 | +3,239 | 182,632 | +2% | +$0 | ||||||
2021-04-05 | DYNT | Dynatronics Corp | Provco Ventures 1 LP | 10% | P - Purchase | $0.00 | +32,564 | 991,813 | +3% | +$0 | ||||||
2021-04-05 | DYNT | Dynatronics Corp | Enright Erin S. | Dir | P - Purchase | $0.00 | +65,164 | 1,697,203 | +4% | +$0 | ||||||
2021-04-05 | DYNT | Dynatronics Corp | Baker Brian D. | Dir | P - Purchase | $0.00 | +4,571 | 76,030 | +6% | +$0 | ||||||
2021-04-05 | DYNT | Dynatronics Corp | Essig Stuart | 10% | P - Purchase | $0.00 | +65,164 | 1,697,203 | +4% | +$0 | ||||||
2021-04-05 | CMD | Cantel Medical Corp | Berman Ann E | Dir | S - Sale | $82.41 | -5,500 | 4,159 | -57% | -$453,255 | ||||||
2021-04-05 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale | $196.15 | -1,487 | 129,294 | -1% | -$291,675 | ||||||
| M | 2021-04-01 | EMED | Electromedical Technologies, Inc | Steinberg Donald J | 10% | S - Sale | $0.19 | -52,220 | 3,648,249 | -1% | -$9,822 | |||||
| M | 2021-04-01 | ICUI | Icu Medical Inc/de | Lopez George A | Dir, 10% | S - Sale | $206.64 | -25,000 | 1,202,157 | -2% | -$5,165,886 | |||||
| D | 2021-04-01 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $130.65 | -10,500 | 45,788 | -19% | -$1,371,786 | |||||
| D | 2021-02-11 | BVS | Bioventus Inc. | Pavesio Alessandra | SVP, Chief Science Officer | P - Purchase | $13.00 | +1,000 | 1,000 | New | +$13,000 | |||||
| D | 2021-02-11 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | P - Purchase | $13.00 | +1,000 | 1,000 | New | +$13,000 | |||||
| D | 2021-02-11 | BVS | Bioventus Inc. | Anglum Gregory O. | SVP, GC | P - Purchase | $13.00 | +6,000 | 6,000 | New | +$78,000 | |||||
| D | 2021-02-11 | BVS | Bioventus Inc. | Reali Kenneth Michael | CEO | P - Purchase | $13.00 | +9,375 | 9,375 | New | +$121,875 | |||||
| D | 2021-02-11 | BVS | Bioventus Inc. | Nosenzo John | Chief Commercial Officer | P - Purchase | $13.00 | +500 | 500 | New | +$6,500 | |||||
2021-02-11 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | P - Purchase | $13.00 | +2,500 | 2,500 | New | +$32,500 | ||||||
2021-04-05 | DCTH | Delcath Systems, Inc. | Michel Gerard J | CEO | P - Purchase | $12.88 | +15,500 | 23,000 | +207% | +$199,640 | ||||||
2021-04-01 | RMD | Resmed Inc | Sodhi Rajwant | Pres, SaaS Business | S - Sale | $194.14 | -1,500 | 30,088 | -5% | -$291,210 | ||||||
2021-04-01 | ATRC | Atricure, Inc. | Collar Mark A | Dir | S - Sale | $65.28 | -3,000 | 77,858 | -4% | -$195,840 | ||||||
| D | 2021-04-01 | SILK | Silk Road Medical Inc | Davis Andrew S. | Chief Commercial Officer | S - Sale+OE | $50.86 | -6,324 | 31,900 | -17% | -$321,654 | |||||
| D | 2021-04-01 | PODD | Insulet Corp | Petrovic Shacey | Pres, CEO | S - Sale+OE | $266.17 | -15,000 | 129,084 | -10% | -$3,992,550 | |||||
| D | 2021-04-01 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale+OE | $134.12 | -7,928 | 650,393 | -1% | -$1,063,303 | |||||
2021-04-01 | BSX | Boston Scientific Corp | Olson Scott | SVP, Pres, Rhythm Management | S - Sale | $38.61 | -700 | 12,844 | -5% | -$27,027 | ||||||
2021-03-31 | SRDX | Surmodics Inc | Olson Charles W | SVP of Bus Dev, Med Dev | S - Sale | $56.75 | -4,759 | 43,540 | -10% | -$270,073 | ||||||
2021-03-30 | LUNG | Pulmonx Corp | Boston Scientific Corp | 10% | S - Sale | $40.80 | -1,350,000 | 4,638,106 | -23% | -$55,080,000 | ||||||
| D | 2021-03-29 | SILK | Silk Road Medical Inc | Buchanan Lucas W. | COO, CFO | S - Sale+OE | $46.73 | -10,000 | 190,290 | -5% | -$467,258 | |||||
| A | 2021-01-19 | DRIO | Dariohealth Corp. | Stern Adam K | Dir | P - Purchase | $0.00 | +43,850 | 83,603 | +110% | +$0 | |||||
2021-03-26 | DXCM | Dexcom Inc | Murphy Patrick Michael | EVP, GC | S - Sale | $350.00 | -500 | 19,741 | -2% | -$175,000 | ||||||
| D | 2021-03-29 | IART | Integra Lifesciences Holdings Corp | Coleman Glenn | EVP, COO | S - Sale+OE | $68.50 | -15,500 | 36,058 | -30% | -$1,061,750 | |||||
| M | 2021-03-26 | EMED | Electromedical Technologies, Inc | Steinberg Donald J | 10% | S - Sale | $0.23 | -25,000 | 3,700,469 | -1% | -$5,837 | |||||
| D | 2021-03-26 | NARI | Inari Medical, Inc. | Tu Thomas | Chief Medical Officer | S - Sale+OE | $103.32 | -5,000 | 39,344 | -11% | -$516,574 | |||||
2021-03-25 | INFU | Infusystem Holdings, Inc | Gendron Paul Andrew | Dir | P - Purchase | $20.34 | +3,000 | 25,000 | +14% | +$61,020 | ||||||
| D | 2021-03-26 | INO | Inovio Pharmaceuticals, Inc. | Shea Jacqueline Elizabeth | COO | S - Sale+OE | $8.97 | -4,710 | 60,127 | -7% | -$42,249 | |||||
| D | 2021-03-25 | TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | GC | S - Sale+OE | $1.56 | -8,758 | 73,256 | -11% | -$13,662 | |||||
| DM | 2021-03-22 | INFU | Infusystem Holdings, Inc | Lehman Gregg Owen | Dir | S - Sale+OE | $21.38 | -50,000 | 346 | -99% | -$1,068,998 | |||||
2021-03-23 | DXCM | Dexcom Inc | Pacelli Steven Robert | Managing Dir., Dexcom Ventures | S - Sale | $360.49 | -1,079 | 54,479 | -2% | -$388,967 | ||||||
2021-03-23 | DXCM | Dexcom Inc | Doubleday Richard | EVP Chief Commercial Officer | S - Sale | $360.49 | -1,109 | 28,208 | -4% | -$399,788 | ||||||
2021-03-19 | EMED | Electromedical Technologies, Inc | Steinberg Donald J | 10% | S - Sale | $0.31 | -10,000 | 3,725,469 | 0% | -$3,100 | ||||||
| D | 2021-03-22 | VAPO | Vapotherm Inc | Ramade Gregoire | SVP, Chief Commercial Officer | S - Sale+OE | $25.82 | -2,000 | 20,614 | -9% | -$51,640 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |